Clinical trial
A Phase III Study of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2
NCT02356276 is registered in ClinicalTrials.gov with Affiliated Cancer Hospital & Institute of Guangzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Study of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2
- Lead sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 11, 2015
- Completion date
- January 31, 2022
- Enrollment
- 584 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer